Additional file 4 of Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape

Additional file 4. Analysis of Progression-Free Survival (PFS), targeted therapy and mutation profile of EGFR single (S) and co-mutation (C) cases (N = 23, Lung cancer patients).